CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alamar Biosciences, Inc.
Sign in to watch- Ticker
- ALMR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364899036
- Phone
- 510-626-9888
- Business address
- 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 10,594,547 shares (conversion)
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy 10% owner bought 235,294 shares at $17.00 ($3,999,998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President acquired 37,220 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 37,220 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 76,509 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 37,220 shares (grant or award)
- 4 Open-market buy Director bought 235,294 shares at $17.00 ($3,999,998)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 2 of 4 · 63 filings